Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 41 Breast Neoplasms 40 Lung Neoplasms 25 Carcinoma, Non-Small-Cell Lung 20 Colorectal Neoplasms 19 Uterine Cervical Neoplasms 13 Prostatic Neoplasms 13 Head and Neck Neoplasms 11 Carcinoma, Hepatocellular 11 Pancreatic Neoplasms 10 Melanoma 10 Ovarian Neoplasms 9 Neoplastic Cells, Circulating 7 Myelodysplastic Syndromes 7 Glioma 7 Esophageal Neoplasms 7 Endometrial Neoplasms 7 Brain Neoplasms 7 Sarcoma 6 Multiple Myeloma 6 Gastrointestinal Neoplasms 6 Carcinoma, Renal Cell 6 Triple Negative Breast Neoplasms 5 Neoplasm Metastasis 5 Leukemia, Myeloid, Acute 5 Disease 5 Colonic Neoplasms 5 Uveal Melanoma 4 Skin Neoplasms 4 Neoplasm, Residual 4

Interventions

Sunitinib 2 spartalizumab 1 pembrolizumab 1 palbociclib 1 enzalutamide 1 bicalutamide 1 avelumab 1 aldesleukin 1 Specimen Handling 1 Receptors, Androgen 1 Leuprolide 1 Interleukin-2 1 Health Information Exchange 1 Goserelin 1 Flutamide 1 Blood Specimen Collection 1 Axitinib 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Diseases × Blood Specimen Collection × 1 year × Clear all

NCT02822404 2026-04-01

CysPed

University Hospital, Toulouse

Phase NA Completed

Kidney Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡